Clear Search sequence regions


  • diagnosis (2)
  • FVL (9)
  • humans (1)
  • plasma (3)
  • protein C (1)
  • risk factor (1)
  • venous thrombosis (1)
  • Sizes of these terms reflect their relevance to your search.

    The factor V Leiden (FVL) polymorphism is known as the most common inherited risk factor for venous thrombosis. In turn, FVL is the leading cause of an activated protein C resistance (APCR) phenotype, in which the addition of exogenous activated protein C to plasma does not result in the expected anticoagulant effect. In the routine laboratory approach to the formal diagnosis of FVL, an initial positive screening plasma-based method for APCR is often performed, and only if needed, this is followed by a confirmatory DNA-based assay for FVL. Multiple methods with accepted sensitivity and specificity for determining an APCR/FVL phenotype are commonly categorized into two separate groups: (1) screening plasma-based assays, including qualitative functional clot-based assays, for APCR, and (2) confirmatory DNA-based molecular assays, entailing several tests and platforms, including polymerase chain reaction-based and non-PCR-based techniques, for FVL. This review will describe the methodological aspects of each laboratory test and prepare suggestions on the indication of APCR and FVL testing and method selection. Thieme. All rights reserved.

    Citation

    Mehran Bahraini, Alieh Fazeli, Akbar Dorgalaleh. Laboratory Diagnosis of Activated Protein C Resistance and Factor V Leiden. Seminars in thrombosis and hemostasis. 2024 Nov;50(8):1067-1083

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 37429328

    View Full Text